Search clinical trials for: ZR202-CoV

Total 4599 results

Sanofi Pasteur, a Sanofi Company
GlaxoSmithKline

Completed

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older (VAT00002)

COVID-19

Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France (COVIDO-DREP)

Sickle Cell Disease
Institut Bergonié

Completed

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic (PRO-SERO-COV)

Sars-CoV2 | Serum; Disease

France
Montana State University
University of Washington; Fred Hutchinson Cancer Center; National Institute of... and other collaborators

Completed

Protecting Our Community: COVID-19 Testing

Covid19 | SARS-CoV-2

United States
Columbia University

Terminated

Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen

Covid19

United States
Regeneron Pharmaceuticals

Terminated

COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease

SARS-CoV-2

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Vitality: Promoting Cognitive Function in Older Adults With Chronic Stroke (Vitality)

Stroke | Chronic Stroke

Canada
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
University of California, Los Angeles

Not yet recruiting

Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

Corona Virus Infection

United States
Instituto Brasileiro de Controle do Cancer

Recruiting

Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 (ASTANA)

Surgery | SARS-CoV-2 | Oncology

Brazil
Pfizer

Completed

Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

Healthy

United States
Technische Universität Dresden
AOK Bayern; Techniker Krankenkasse; InGef - Institut für angewandte Gesundheitsforschung... and other collaborators

Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data (POINTED)

Virus Diseases | Epidemiology

Germany
Universitätsklinikum Köln
Hannover Medical School; Miltenyi Biomedicine GmbH; ZKS Köln

Terminated

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19 (ACT-COVID-19)

Moderate COVID-19-infection

Germany
Everly Health

Completed

A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

SARS-CoV-2 Acute Respiratory Disease

United States
Adaptive Biotechnologies
Covance

Completed

ImmuneSense™ COVID-19 Study

SARS-CoV-2 Infection | Coronavirus Disease (COVID-19)

United States
Magdalena Salcedo

Unknown

Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients

Liver Transplant Infection | Covid19 | Mortality | Immune Response

Spain
Johns Hopkins University

Completed

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

SARS-CoV-2 Infection

United States
Kern Medical Center

Completed

Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic

COVID-19 | Social Determinants of Health | Penetrating Injury

United States
Technische Universität Dresden
Techniker Krankenkasse; InGef - Institut für angewandte Gesundheitsforschung... and other collaborators

Completed

Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD) (POINTED-AD)

Virus Diseases

Germany
University of Calgary

Completed

Clinical Characteristics and Outcomes of Pediatric COVID-19 (PERN-COVID-19)

COVID-19 | Pneumonia, Viral | Pediatric ALL | SARS-CoV-2 Infection | Pandemic Response

Canada
Vatic Ltd.

Unknown

Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen

Covid19
Senhwa Biosciences, Inc.

Not yet recruiting

Phase II, Double Blind, Randomized Trial of CX-4945 in Viral Community Acquired Pneumonia

Community-acquired Pneumonia | Influenza With Pneumonia | SARS-CoV-2 -Associated Pneumonia

Taiwan
Noah Merin
Johns Hopkins University

Terminated

Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure

Covid-19 | Sars-CoV2

United States
Shanghai Municipal Center for Disease Control and...
China National Biotec Group Company Limited

Not yet recruiting

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Measles | Rubella | Mumps | Varicella | SARS-CoV-2 Infection

China
National Institute of Allergy and Infectious Diseases...

Completed

Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

COVID-19

United States
Novavax

Active, not recruiting

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19

United States
Sanofi Pasteur, a Sanofi Company

Terminated

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older (VAW00001)

COVID-19

United States, Australia, Brazil, Honduras
GeoVax, Inc.
National Cancer Institute (NCI); City of Hope Medical Center

Active, not recruiting

A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection

COVID-19 Infection

United States
University of Milano Bicocca
San Gerardo Hospital

Completed

Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study (Hema-C19-Vax)

Hematologic Diseases

Italy
University Hospital, Bordeaux

Recruiting

Virus and Bronchial Epithelium in Children and the Elderly (VIRCHILLD)

SARS-CoV-2

France
Manchester University NHS Foundation Trust

Completed

Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) (FALCON-C19)

COVID-19 | Coronavirus Infection

United Kingdom
Testing Done Simple
Nao Medical Urgent Care

Completed

Assessing Performance of the Testing Done Simple Covid 19 Antigen Test

COVID-19

United States
Hospitales Universitarios Virgen del Rocío

Active, not recruiting

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

HIV Infection | SARS-CoV-2 RNA Vaccines

Spain
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Hasselt University; Jessa Hospital; Ziekenhuis Oost-Limburg

Unknown

Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study (COVITRA)

Covid19 | SARS-CoV Infection | Transplantation Infection

Belgium
University Hospital, Tours

Not yet recruiting

Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19 (MUCOVID)

Certain Disorders Involving the Immune Mechanism

France
University of Ioannina

Recruiting

The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19

Covid19 | End Stage Kidney Disease | Vaccination | Kidney Transplantion

Greece
Oslo University Hospital

Active, not recruiting

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) (SCV-KTx-imm)

Kidney Transplant Infection | SARS-CoV Infection

Norway
Medical University of Graz
Lagos State University; Walter Sisulu University; Management Sciences for Health and other collaborators

Enrolling by invitation

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa (ENDOCOVID)

Covid19 | Hiv | ART

Nigeria, South Africa
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

COVID-19 and Venous Thromboembolism Risk

Covid19 | Venous Thromboembolism

United States
University Medical Center Groningen
Radboud University Medical Center; Erasmus Medical Center; Academisch Medisch...

Completed

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study (RECOVAC-IR)

Covid19 | Chronic Kidney Diseases

Netherlands
University of Cagliari

Completed

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Covid19 | Surgery | SARS (Severe Acute Respiratory Syndrome)

Italy
Children's Hospital Medical Center, Cincinnati

Active, not recruiting

Antibody Detection of Vaccine-Induced Secretory Effects (ADVISE)

Covid19 | SARS-CoV Infection | Coronavirus | Humoral Acquired Immunodeficiency

United States
AnteoTech Ltd

Terminated

EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO) (WHO)

SARS-CoV-2 Infection

Croatia, Greece, Spain
University Hospital, Caen

Completed

COVID-19 Vaccines Associated Malaise

Vaccine Adverse Reaction

France
Federico II University

Unknown

Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy (COVID-preg)

Infection Viral

Italy
Federico II University

Unknown

Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. (I-COVID)

Infection Viral

Italy
Universidad de Antioquia
Laboratorio departamental de salud publica de Antioquia; Sistema general de...

Recruiting

Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory.

Covid19

Colombia
PT Bio Farma
Fakultas Kedokteran Universitas Indonesia; Faculty of Medicine, Diponegoro...

Completed

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018

COVID-19

Indonesia
Korea University Guro Hospital
Korean Center for Disease Control and Prevention

Active, not recruiting

Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)

COVID-19 (Healthy Volunteers)

Korea, Republic of
PT Bio Farma
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine

Covid19

Indonesia

Search clinical trials for: ZR202-CoV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations